209 related articles for article (PubMed ID: 12449100)
41. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
[TBL] [Abstract][Full Text] [Related]
42. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo.
Siner JM; Jiang G; Cohen ZI; Shan P; Zhang X; Lee CG; Elias JA; Lee PJ
FASEB J; 2007 May; 21(7):1422-32. PubMed ID: 17264168
[TBL] [Abstract][Full Text] [Related]
43. IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach.
Selleck WA; Canfield SE; Hassen WA; Meseck M; Kuzmin AI; Eisensmith RC; Chen SH; Hall SJ
Mol Ther; 2003 Feb; 7(2):185-92. PubMed ID: 12597906
[TBL] [Abstract][Full Text] [Related]
44. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
45. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
[TBL] [Abstract][Full Text] [Related]
46. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer.
Braudeau C; Bouchet D; Tesson L; Iyer S; Rémy S; Buelow R; Anegon I; Chauveau C
Gene Ther; 2004 Apr; 11(8):701-10. PubMed ID: 14973545
[TBL] [Abstract][Full Text] [Related]
47. Relationship of acute lung inflammatory injury to Fas/FasL system.
Neff TA; Guo RF; Neff SB; Sarma JV; Speyer CL; Gao H; Bernacki KD; Huber-Lang M; McGuire S; Hoesel LM; Riedemann NC; Beck-Schimmer B; Zetoune FS; Ward PA
Am J Pathol; 2005 Mar; 166(3):685-94. PubMed ID: 15743781
[TBL] [Abstract][Full Text] [Related]
48. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice.
Yet SF; Perrella MA; Layne MD; Hsieh CM; Maemura K; Kobzik L; Wiesel P; Christou H; Kourembanas S; Lee ME
J Clin Invest; 1999 Apr; 103(8):R23-9. PubMed ID: 10207174
[TBL] [Abstract][Full Text] [Related]
49. Heme oxygenase-2 gene deletion increases astrocyte vulnerability to hemin.
Chen J; Regan RF
Biochem Biophys Res Commun; 2004 May; 318(1):88-94. PubMed ID: 15110757
[TBL] [Abstract][Full Text] [Related]
50. Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer.
Lee JK; Sayers TJ; Back TC; Wigginton JM; Wiltrout RH
Apoptosis; 2003 Mar; 8(2):151-60. PubMed ID: 12766475
[TBL] [Abstract][Full Text] [Related]
51. Protection against ozone-induced pulmonary inflammation and cell death by endotoxin pretreatment in mice: role of HO-1.
Li L; Hamilton RF; Holian A
Inhal Toxicol; 2000 Dec; 12(12):1225-38. PubMed ID: 11203434
[TBL] [Abstract][Full Text] [Related]
52. Human heme oxygenase: cell cycle-dependent expression and DNA microarray identification of multiple gene responses after transduction of endothelial cells.
Abraham NG; Scapagnini G; Kappas A
J Cell Biochem; 2003 Dec; 90(6):1098-111. PubMed ID: 14635185
[TBL] [Abstract][Full Text] [Related]
53. Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway.
Wallach-Dayan SB; Izbicki G; Cohen PY; Gerstl-Golan R; Fine A; Breuer R
Am J Physiol Lung Cell Mol Physiol; 2006 Apr; 290(4):L790-L796. PubMed ID: 16306138
[TBL] [Abstract][Full Text] [Related]
54. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
[TBL] [Abstract][Full Text] [Related]
55. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
56. The transcription factor NRF2 protects against pulmonary fibrosis.
Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
[TBL] [Abstract][Full Text] [Related]
57. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.
Tran PL; Weinbach J; Opolon P; Linares-Cruz G; Reynes JP; Grégoire A; Kremer E; Durand H; Perricaudet M
J Clin Invest; 1997 Feb; 99(4):608-17. PubMed ID: 9045862
[TBL] [Abstract][Full Text] [Related]
58. Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.
Chirmule N; Moscioni AD; Qian Y; Qian R; Chen Y; Wilson JM
Hum Gene Ther; 1999 Jan; 10(2):259-69. PubMed ID: 10022550
[TBL] [Abstract][Full Text] [Related]
59. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
60. Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer.
Zadelaar AS; von der Thüsen JH; Boesten LS; Hoeben RC; Kockx MM; Versnel MA; van Berkel TJ; Havekes LM; Biessen EA; van Vlijmen BJ
Atherosclerosis; 2005 Dec; 183(2):244-50. PubMed ID: 15927188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
